In ovarian cancer, miR-21 can be transferred from CAFs to ovarian cancer cells, where it suppresses apoptosis and confers chemoresistance by binding to its recently discovered direct target, APAF1 (143). The gene discussed is APAF1; the disease is ovarian cancer.